Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00397293

Femme et Homme

Extrait

This is an open label, multicenter Phase I/II study to evaluate the safety and efficacy of AT-101 in combination with topotecan in relapsed/refractory small cell lung cancer


Critère d'inclusion

  • Small Cell Lung Cancer

Liens